- Home
- SMJF vs KYNB Comparison
SMJF vs KYNB Comparison
Compare SMJF & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SMJF | KYNB |
|---|---|---|
| Founded | 1988 | 1993 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.5M | 32.8M |
| IPO Year | 2025 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SMJF | KYNB |
|---|---|---|
| Price | $1.53 | $4.68 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $38.50 |
| AVG Volume (30 Days) | ★ 508.7K | 22.2K |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9552.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,440,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.12 |
| P/E Ratio | $68.08 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.82 | $4.32 |
| 52 Week High | $11.48 | $9.66 |
Technical Indicators
Market Signals| Indicator | SMJF | KYNB |
|---|---|---|
| Relative Strength Index (RSI) | 40.40 | 26.58 |
| Support Level | $0.95 | N/A |
| Resistance Level | $3.72 | $7.41 |
| Average True Range (ATR) | 0.23 | 0.36 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 8.33 | 11.64 |
Price Performance
Historical ComparisonAbout SMJF SMJ International Holdings Inc. Class A Ordinary Shares
SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, polypropylene tiles, broadloom carpets, and vinyl tiles. It operates under the proprietary brand 'SMJ'. The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. Geographically, it has a presence across Malaysia, Indonesia, the Philippines, Vietnam, India, Singapore, and other markets. The company generates revenue mainly through the sale and distribution of its flooring products, prominently in Singapore.
About KYNB Kyntra Bio Inc. Common Stock
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.